Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024Translational Lung Cancer ResearchOpen Access

Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications

View Full Paper
Ask AI
Bookmark
Share

Authors

XSXiaojuan SuYFYi FengYQYi Qu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Su et al. (2024) studied this question.

synapsesocial.com/papers/68e6c033b6db64358763f8a5https://doi.org/10.21037/tlcr-24-85
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Analysis of the Oncogenic Role of Methyltransferase Like 3 (METLL3) in Head and Neck Squamous Cell Carcinoma (HNSCC)2024 · 1 citations
  2. 2<scp>METTL3</scp>/<scp>IGF2BP1</scp> influences the development of non‐small‐cell lung cancer by mediating <scp>m6A</scp> methylation modification of <scp>TRPV1</scp>2024 · 4 citations
  3. 3METTL3 as a potential predictive biomarker for immunotherapy response in metastatic head and neck cancer.2024
  4. 4METTL3 Contributes to the Advancement of Non-Small Cell Lung Cancer by Regulating m6A RNA Methylation-Mediated Degradation of FBXO332025
  5. 5A meta analysis of subtype-specific prognostic significance of METTL3 expression in non-small cell lung cancer2025